Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record Methodology

Covered recipient · General Payments record

CHERRY D WALLACE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology

NPI
1013886456
CMS profile
11922914
Location
SAINT LOUIS, MO

General Payments · PY2025

$272.09

  • Reported across 15 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$272.09

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $272.09 15

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $223.56 13
Axsome Therapeutics, Inc. $29.90 1
Acerta Pharma LLC $18.63 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2025 $272.09 15

Payment records · PY2025 (15)

Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them

Program year 2025
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.63 10/10/2025 Food and Beverage Undisputed 06/30/2026 1206531984 CMS
Axsome Therapeutics, Inc. $29.90 12/11/2025 Food and Beverage Undisputed 06/30/2026 1235679417 CMS
Boston Scientific Corporation $25.72 05/08/2025 Food and Beverage Undisputed 06/30/2026 1181574015 CMS
Boston Scientific Corporation $7.97 06/04/2025 Food and Beverage Undisputed 06/30/2026 1181574017 CMS
Boston Scientific Corporation $23.21 06/20/2025 Food and Beverage Undisputed 06/30/2026 1181574019 CMS
Boston Scientific Corporation $28.43 07/21/2025 Food and Beverage Undisputed 06/30/2026 1181574021 CMS
Boston Scientific Corporation $4.89 07/30/2025 Food and Beverage Undisputed 06/30/2026 1181574023 CMS
Boston Scientific Corporation $28.73 08/22/2025 Food and Beverage Undisputed 06/30/2026 1181574025 CMS
Boston Scientific Corporation $4.85 09/11/2025 Food and Beverage Undisputed 06/30/2026 1181574029 CMS
Boston Scientific Corporation $30.27 09/18/2025 Food and Beverage Undisputed 06/30/2026 1181574027 CMS
Boston Scientific Corporation $4.73 10/16/2025 Food and Beverage Undisputed 06/30/2026 1181574031 CMS
Boston Scientific Corporation $3.82 11/03/2025 Food and Beverage Undisputed 06/30/2026 1181574033 CMS
Boston Scientific Corporation $23.40 11/04/2025 Food and Beverage Undisputed 06/30/2026 1181574037 CMS
Boston Scientific Corporation $31.63 11/05/2025 Food and Beverage Undisputed 06/30/2026 1181574035 CMS
Boston Scientific Corporation $5.91 12/04/2025 Food and Beverage Undisputed 06/30/2026 1181574039 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2025
Source files
Dataset page · Bulk file · PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.